The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The SURVIVE study: Liquid biopsy guided surveillance after intermediate- to high-risk early breast cancer.
 
Kerstin Pfister
Honoraria - Gilead Sciences; Pfizer
 
Sophia Huesmann
No Relationships to Disclose
 
Thomas W. P. Friedl
Honoraria - Lilly; Novartis
 
Angelina Fink
No Relationships to Disclose
 
Forca Mehmeti
No Relationships to Disclose
 
Franziska Mergel
No Relationships to Disclose
 
Henning Schäffler
No Relationships to Disclose
 
Sabine Heublein
Honoraria - Clovis Oncology; GlaxoSmithKline; Novartis; Pfizer
Consulting or Advisory Role - GlaxoSmithKline; Merck Sharp & Dohme; Novartis
Research Funding - Heuer Stieftung für medizinische Forschung
 
Andreas Daniel Hartkopf
Honoraria - Agendia; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Hexal; Lilly; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Agendia; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Hexal; Lilly; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; Roche; Seagen
Speakers' Bureau - Agendia; Amgen; AstraZeneca; Clovis Oncology; Daiichi Sankyo; Eisai; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Hexal; Lilly; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; Roche; Seagen
Research Funding - Exact Sciences (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Gilead Sciences; Pfizer; Roche
 
Volkmar Mueller
Honoraria - AstraZeneca; Daiichi Sankyo; Eisai; Gilead Sciences; GlaxoSmithKline; Medac; Medscape; MSD; Novartis; Onkowissen; Pfizer; Pierre Fabre; Roche; Seagen
Consulting or Advisory Role - Amgen; ClinSol; Daiichi Sankyo; Eisai; Gilead Sciences; Lilly; MSD; Novartis; Pierre Fabre; Roche; Sanofi; Seagen; Stemline Therapeutics
Research Funding - Genentech (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Pfizer; Roche
 
Lisa Maria Wiesmueller
No Relationships to Disclose
 
Tanja N. Fehm
No Relationships to Disclose
 
Klaus Pantel
Honoraria - Abcam; Agena Bioscience; Atheneum; Bristol Myers Squibb Foundation; DeciBio; Guardant Health; Hummingbird; Illumina; Inflection Biosciences; Menarini Silicon Biosystems; Merck KGaA; Molecular Health; MSD; Novartis; Roche; Sanofi; tactics
Consulting or Advisory Role - Agena Bioscience; Guardant Health; Hummingbird Diagnostics; Menarini Silicon Biosystems; Sanofi
Research Funding - Cancer-ID (Inst); Janssen Diagnostics
Patents, Royalties, Other Intellectual Property - application No. 07825055.2; application No. 10004180.5; application No. 17157020.3 - 1405; application No. 95108760.7; Application no. WO2016 128125A1
Travel, Accommodations, Expenses - Agena Bioscience
 
Brigitte Rack
Honoraria - AstraZeneca; Daiichi Sankyo; Roche
Research Funding - Cellgen (Inst); Eisai (Inst); Guardant Health (Inst); Inivata (Inst); Lilly (Inst); Menarini (Inst); Roche (Inst)
 
Wolfgang Janni
Honoraria - AstraZeneca; Cellgen; Chugai Pharma; Daiichi Sankyo; Eisai; Exact Sciences; GlaxoSmithKline; Janssen; Lilly; Menarini; MSD; Novartis; Pfizer; Roche; Sanofi Aventis GmbH; Seagen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Menarini; Novartis; Pfizer; Roche; Seagan
Research Funding - Amgen (Inst); Janssen; Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Roche (Inst)